While I agree that some people are being prescribed GLP-1s that probably should not be (in the sense that they could achieve similar efficacy through non-pharmaceutical interventions such as diet/exercise), I think for a significant majority of recipients, the metabolic effects of this class of drugs is profound and their benefit far outweighs the risk. Of course, we see clinically significant reductions not only in HbA1c and stronger blood glucose control for T2DM patients as well as prediabetics--as these are the originally intended drug targets--but we also see concomitant reductions in cardiovascular risk, significant reductions in obesity, improved activities of daily living, and an interesting inhibitory effect on non-appetite related cravings (e.g., alcohol, tobacco, and drug use) that was not originally foreseen.
To say that these drugs are too risky and overprescribed based on rare but serious side effects is to dismiss huge benefits for a population of patients whose comorbidities were uncontrolled and essentially had one foot in the grave.
Again, I want to emphasize that GLP-1s are not for everyone, not even for everyone with obesity or T2DM. They have profound effects on the metabolism. We knew this ever since exenatide was developed over a decade ago. That's why they are prescription only. You need to have a doctor evaluate your use on a regular basis. People need to understand that we are all unique in our response to drugs, and that the "average" person doesn't exist. That's why we do clinical trials and postmarketing surveillance--which is also how we caught this particular risk.
Nobody (except anti-science assholes with an agenda) argues against allowing chemotherapy for late stage cancer patients even though they are cytotoxic. You weigh the risk against the benefit. If chemotherapy means one might get 6 months more life, even if it's not pain-free, that's up to the patient to decide. To paint it with a broad brush and argue for denying anyone such treatment because a small fraction of patients won't respond or will experience serious side effects, is barbaric and insane. Yet people hear about some rare but serious side effect in a drug with literal life-saving potential, and demand it be withdrawn from market. That's equally insane.
Yes, there are people who are getting access to this class of drugs who probably don't need it. This phenomenon is not unique to GLP-1s--it's just particularly noticeable in this case because of our society's emphasis on physical appearance. But to suggest that the incidence of obesity was lower in previous generations as some justification for restricting access is wild. It offers no solution for the social, cultural, and economic reasons for the rise in obesity in the first place, so it rings hollow to say GLP-1s are overprescribed while staying silent about the predatory practices of the food industry and how they manipulate the consumption habits of people; the dismantling of physical and dietary education programs in schools; the lack of funding and political resistance to providing healthy school meals; the existence of "food deserts" and proliferation of fast food in economically depressed areas; etc. Medical professionals have been watching this trend with horror and have been repeatedly telling everyone to diet and exercise for the past 50+ years, to no avail. It's not like they haven't tried. The insinuation that the vast majority of obese people are obese by choice and/or lack of sufficient self-control, is an old, old trope that serves no one and needs to die. It doesn't make any sense in a society that is so fixated on superficial physical appearance that people are actively shunned for being overweight.